Editorial: Towards optimal thiopurine therapy for inflammatory bowel disease-authors' reply

Aliment Pharmacol Ther. 2024 Mar;59(6):794. doi: 10.1111/apt.17895.

Authors

Abhinav Vasudevan^{1

2}, Danny Con³, Daniel R van Langenberg^{1

2}

Affiliations

¹ Department of Gastroenterology and Hepatology, Eastern Health, Box Hill, Australia.
² Monash University, Eastern Health Clinical School, Box Hill, Victoria, Australia.
³ Department of Gastroenterology, The Austin Hospital, Melbourne, Australia.

PMID: 38401137
DOI: 10.1111/apt.17895

No abstract available

Publication types

Editorial

MeSH terms

Humans
Inflammatory Bowel Diseases* / drug therapy
Purines
Sulfhydryl Compounds

Substances

2-mercaptopurine
Purines
Sulfhydryl Compounds